Higher levels of C3b/iC3b, a split product of C3, and factor I were also reported in female compared to male patients, suggesting a counter regulatory mechanisms in women, who are more prone to develop RA (Bemis et al., 2019). The gene discussed is C3; the disease is rheumatoid arthritis.